Ten-years ago while probing the surfaces of murine lymphocyte sub-populations for terminal Nacetylglucosamine (GlcNAc) moieties using bovine milk galactosyltransferase and UDP-[3H]galactose, we found that many lymphocyte proteins contained single 0-glycosidically linked GlcNAc residues (1). Detergent latency experiments also demonstrated that the vast majority of these 0-GlcNAc glycoproteins were nucleoplasmic or cytosolic. Studies of rat liver subcellular fractions showed 0-GlcNAc to be greatly enriched in nuclear fractions (2). Later studies of highlypurified, 100% viable lymphocytes showed 0-GlcNAc to be localized exclusively in nucleoplasm or cytoplasm (3). Fig. 1 , which shows a 2D-gel analysis of 0-GlcNAc proteins from liver nuclei that are radiolabeled by galactosyltransferase, illustrates the large numbers of these glycoproteins in the nucleus.
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The 0-GlcNAcase is effectively inhibited by various analogs of GlcNAc including 1 -amino-GlcNAc, 1-azido-GlcNAc, LOGNAC (ki=l.7 mM) and PUGNAC (Ki=52 nM). It is likely that the excellent inhibitory activities of these analogs will be important tools when studying the dynamics of 0-GlcNAc on various cellular proteins.
Nuclear Pore Proteins Bearing 0-GlcNAc
Nuclear envelope is particularly enriched in 0-GlcNAc-bearing proteins (55) . Most of the monoclonal antibodies originally prepared against nuclear pore proteins (nucleoporins) (56) have 0-GlcNAc as a large part of their epitopes. Nucleoporins are involved in the transport of macromolecules into and out of the nucleus (57, 58) . Microinjection of a lectin, WGA, which binds GlcNAc, (59) or a monoclonal antibody to 0-GlcNAc (56) prevents both import of proteins and export of RNA from the nucleus (60) . Steric problems associate with such a large lectin (or antibody) were ruled-out since WGA appeared to only block proteins translocation with little effect on binding of proteins to the pore complex (61) . Reconstitution experiments have shown that the nucleoporins are essential for nuclear transport but not the gross structure of the nuclear pores themselves (62) .
Chromatin Proteins Bearing 0-GlcNAc
Early work showed that chromatin contained a large number of 0-GlcNAc bearing protiens (55). In fact, WGA binding and galactosyltransferase labeling studies of Drosophila embryo polytene chromosomes have shown that 0-GlcNAc is highly abundant along the entire length of the chomosomes (42) . Furthermore, the 0-GlcNAc moieties appear to be particularly concentrated in condensed regions of the chromatin resulting in a banded pattern, while much less 0-GlcNAc is present in 'puff regions which have been associated with areas of active transcription.
Recently, RNA polymerase I1 (RNA Pol 110) (14) and all of its transcription factors, thus far investigated (19) (20) (21) (22) , have been shown to be modified by 0-GlcNAc. Glycosylated transcription factor Spl has been reported to be more transcriptionally active than the non-glycosylated form (19) . Glycosylated Spl appears to play a role in insulin-dependent stimulation of growth factor TGFa (63) , and Spl appears to be differentially glycosylated in a cell-type specific manner (64).
The catalytic subunit of RNA Pol 11 contains a highly conserved domain at the carboxyl-terminus consisting of up to 52 repeat units with consensus sequence:-(Tyr-Ser-Pro-Thr-Ser-Pro-Ser)-[for review see (65) . Genetic analysis has demonstrated that this C-terminal domain (CTD) is required for cell viability Furthermore, various forms of the RNA Pol I1 subunits have been demonstrated in vivo based the phosphorylation state of the CTD and on its mobility by SDS-PAGE. These include 11, (Mr 240), which is the highly phosphorylated over the entire repeat region of the CTD and is associated with the transcription complex during the transition from initiation to elongation (66) , and 11, [Mr 215 kDa] the non-phosphorylated form found in the preinitiation complex (67) . We have shown that the CTD of II,, but not II,, is extensively modified by 0-GlcNAc over the entire conserved repeat region (14) . Thus, the phosphorylation and glycosylation of the CTD appear to be mutually exclusive events suggesting a high degree of regulation. We hypothesize that the 0-GlcNAc modified form (IIa) is involved in the formation of the initiation complex, possibly by oligomerization with 0-GlcNAc modified transcription factors via lectin-like protein(s) or by carbohydratecarbohydrate interactions. After formation of the initiation complex, it appears that the RNA polymerase IIa is rapidly deglycosylated and then rapidly phosphorylated to form the 110 form involved in transcriptional elongation. Fig. 2 illustrates this model of the putative role of 0-GlcNAc in transcriptional initiation. The putative transcriptional regulatory role for 0-GlcNAc is presently under active investigation.
In addition to 'normal' transcription factors, nuclear oncogene proteins, such as c-myc (3 1) and vErb-a (29) are also modified by 0-GlcNAc. Interestingly, c-myc appears to be predominantly modified in its transactivation domain, suggesting a role for the saccharide in its action as a transcription factor activating neoplastic growth.
Several other nuclear proteins have been demonstrated to contain 0-GlcNAc modifications (Table  1) including bovine and mouse estrogen receptor (Jiang & Hart, unpublished), Aplasia neuron 83 kDa protein (26, 27) and canine autoantigen p43 (34,3 5). For the estrogen receptor, considerable evidence is now available that phosphorylation may be crucial to the regulation of estrogen-responsive Here again, like other 0-GlcNAc bearing proteins, the glycosylation may act as an antagonist to phosphorylation and thereby also have a role in gene expression. It is also worth noting that the 83 kDa protein from Aplasia neurons is prominent in both the axon and the nucleus (26). Given that a pathway was recently discovered in neurons that can transport proteins from the axon to the nucleus (27) , it will be interesting to know whether this glycoprotein is involved with the transport mechanism.
Cytoskeletal Glycoproteins
Many of the cytosolic 0-GlcNAc modified proteins that have been identified are components of the cytoskeleton. Human erthrocyte Band 4.1 (50) was among the first to be characterized. Band 4.1 is involved in maintaining the unique shape of erthrocytes by anchoring actin and spectrin to the cytoplasmic tail of glycophorin. Recently, cytokeratins 13 (1 5), 8 and 18 (1 6 ) were shown to contain 0-GlcNAc. Both phosphorylation and 0-GlcNAc modification are enriched during mitotic arrest (17) 
. Cytokeratins are a class of intermediate filaments found mostly in epithelial cells (69).
Cytokeratin assembly is known to be regulated by phosphorylation (70) . The relationship between cytokeratins glycosylation and phosphorylation is not yet well-understood.
We recently have shown that neurofilaments from rat and mouse spinal cord are multiply glycosylated. The 0-GlcNAc modifications on neurofilaments were localized primarily in the head domain of both neurofilaments M and L (23). The head domain is a region of the proteins that had already been implicated as being required for proper neurofilament assembly by deletion analysis (71, 72) . Site directed mutagenesis of the sites of 0-GlcNAc modification are presently underway to address whether the glycosylation is required for assembly of these filaments.
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Fig the Paired Helical Filaments Characteristic in Alzheimer's Patients Brain Cells.
During studies on neurflaments from rat brain, the microtubule-associated protein, Tau, was also found to be extensively modified by 0-GlcNAc. Normally, Tau facilitates microtubule assembly, but in Alzheimer's brains it is abnormally phosphorylated at specific -Ser(Thr)-Pro-and subsequently forms long paired helical filaments (PHF-Tau; Fig. 3 ).
PHF-Tau is characteristically present in the brain cells of pateints with Alzheimer's disease, but not in the brain cells of normal individuals. The finding that Tau is normally glycosylated, suggests that its abnormal phosphorylation in Alzheimer's disease could be related to a defect in addtion or removal of 0-GlcNAc. Fig. 3 shows a model of normal and PHF-Tau. Fig. 4 illustrates the phosphorylation sites on Tau. Note how they are similar to the 0-GlcNAc sites described in Table 2 . Mapping of the sites on the Tau protein is underway.
Finally, the cytoskeletal protein talin has also been reported to be modified by 0-GlcNAc (38) . This important cytosolic protein appears to provide a bridge between the cytoplasmic domain of integrins and the cytoskeleton by interaction with another cytosolic protein, vinculin. Interestingly, non-glycosylated talin derived from platelets does not interact with vinculin, suggesting that 0-GlcNAc may be necessary for the interaction of these cytoskeletal components (38) .
0-GlcNAc and Protein Synthesis
has been described that can bind to eIF-2 and protect it from phosphorylation by eIF-2 kinases and thereby maintain protein synthesis initiation (28, 73) . When p67 was removed from the cell extracts with the lectin, wheat germ agglutinin, or with antibodies to p67, phosphorylation was no longer blocked and the kinases could readily transfer phosphate to the a-subunit of eIF-2. Using antibodies to detect all p67 proteins, and a monoclonal antibody that reacts only with glycosylated p67, it was shown that p67 was first deglycosylated within 10 hrs, then degraded after 16 hr of serum starvation, while the levels of the a and R-subunits of eIF-2 remained constant. It was concluded that p67 protected the a-subunit from phosphorylation under normal conditions, but during starvation, p67 is rapidly deglycosylated then degraded, which allows the eIF-2 kinases to phophorylate the elF-2 and prevent proteins synthesis initiation (74) . Reticulocyte lysates contain a 'deglycosylase' (0-GlcNAcase) that remains in a latent form in the presence of hemin, however, when hemin is absent, the deglycosylase is activated to remove 0-GlcNAc from p67 and begin the cascade toward inhibition of proteins synthesis (Gupt et al., pres. at SOC. Complex CHO, 1993). These provide direct evidence for a role of 0-GlcNAc in protein synthesis initiation.
Viral Proteins
0-GlcNAc-modifications have been demonstrated on a number of viral proteins ( Table 1) . The fiber proteins of adenovirus is known to form mature trimeric structures that are involved in virus attachment to the host cell surface (75) . The 0-GlcNAc in the mature trimeric structures is inaccessible to labeling with GT unless the fibers are denatured with detergents, indicating that the 0-GlcNAc moieties are buried in the trimeric structures (37) . A similar obsevation has been made for neurofilament assembly, suggesting that 0-GlcNAc may also be involved with the formation of these multimeric fiber structures. 0-GlcNAc is also found on the major tegument proteins (the region between the viral capsid and the viral envelope) of human cytomegalovirus (HCMV) (39, 40) and baculovirus (41) . The function of the basic phosphoprotein (BPP, UL32) of HCMV is presently unknown, but its location in the tegument region of the virus suggests that it might act as a signal for final envelopment of the capsid. 0-GlcNAc could be the signal for oligomerization of the BPP or the means of attachment to the cellular compartment used for viral envelopment. The demonstration that gp4 1 of baculovirus contains 0-GlcNAc, made it clear that insect cells are fully capable of adding this modification to proteins. The finding of 0-GlcNAc in baculovirus overexpression systems, has proven valuable to the study of the glycosylation of many low abundance proteins that contain 0-GlcNAc including transcription factors and oncogenes. Importantly, the BPP from HCMY appears to be glycosylated at the same sites when expressed in insect cell as a recombinant baculovirus or when isolated from HCMV virions, although the stoichiometry at each site appeared to be slightly different (40) . These results are also consistent with those found for human cytokeratins 8 and 18 expressed in baculovirus (18).
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Summary and Conclusions
At present, it appears that many of the cell's regulatory and cytoskeletal proteins are transiently glycosylated by 0-GlcNAc. Circumstantial evidence suggests that the saccharide is mediating the assembly of these polypeptides into functional complexes. Direct evidence on several proteins suggests that 0-GlcNAc plays a reciprocal role to phosphorylation. 0-GlcNAc modification of transcription factors and RNA polymerase I1 appears to directly regulate transcriptional initiation. We have assembled the tools for elucidating the functions of this novel post-translational modification. In the near future detailed data with respect to its functions at the molecular level (should be forthcoming.
